Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Address
451 D STREET, 5TH FLOOR
BOSTON, MA 02210
Founded
2011
Number of Employees
32
Website
http://www.elicio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)